Oncology Stocks to Watch (or Trade) into ASCO 2015
Research - The annual meeting of the American Society of Clinical Oncology is almost here. Here are a number of names to watch, and potentially trade, into the event.
Read nowAuthor Archives: Editorial Staff
Our Top Stories from this Week in Healthcare
Insights - The talk of a bubble in biotech seems to have subsided (temporarily, no doubt), and the sector-tracking iShares Nasdaq Biotech ETF (IBB) has continued higher … Continue Reading
Read nowA Heavy Dose of M&A this Week in Healthcare
Dyax Adds Over $1 Billion in Market Value on Early Drug Results
Insights - Dyax Corp. (DYAX) saw a gain of over 40% in pre-market trading Wednesday with the release of phase 1b results for DX-2930, an inhibitor of … Continue Reading
Read now
AN INVESTOR’S GUIDE TO THE “GOING PUBLIC” PROCESS
Education - One of the primary reasons that private companies go public is to lower the cost and increase the efficiency of raising additional capital. However, investors who are not … Continue Reading
Read now
Uh oh. Bubble Talk is Back in Biotech
Recap - Healthcare stocks were routed early this week, falling 10% (based on the NASDAQ Biotech Index) before a bounce from mid-week into Friday. The similarities to … Continue Reading
Read now
OHRP Drops on Latest Clinical Trial Results
Insights - Top-line results from Ohr Pharmaceuticals’ (OHRP) phase II IMPACT study, testing its squalamine eyedrops in age-related macular degeneration (wet-AMD), had a crushing effect on the stock Friday. … Continue Reading
Read now